BUY ALERT: These High-Growth TSX Pot Stocks Are on Sale

These TSX pot stocks are trading dirt cheap and have the potential to generate strong returns in the long run.

Value for money

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The uncertain economic conditions have made investing tough, especially for young investors looking to build a retirement portfolio. The pandemic-led crisis has disrupted almost all the sectors and forced many companies to scale back or shut down their operations.

While many continue to struggle for their survival, few others have shown promise with a significant recovery in their stock prices. Despite the recent bull run, few TSX stocks are still trading low and have the potential to generate stellar returns in the long term.

Take the example of these two TSX pot stocks Hexo (TSX:HEXO)(NYSE:HEXO) and Neptune Wellness Solutions (TSX:NEPT)(NASDAQ:NEPT). Shares of both companies have been battered badly over the past year. Meanwhile, the broader market sell-off in March further weighed on their stocks. Both these stocks showed a strong recovery in the recent past, yet they are trading dirt-cheap prices, providing a solid entry point for investors with a long-term mindset.

Hexo

As I’ve said earlier, I see a significant growth opportunity in this cannabis stock. Hexo stock is trading under $1 and has declined over 54% year to date.

Despite structural issues plaguing the industry, Hexo has performed well. The company’s focus on growing revenues, driving down costs, and expansion of market share bodes well for future growth.

Investors should note that Hexo has received full licensing for its Belleville facility, which is likely to bolster its production capacity and help in expanding its product portfolio.

Hexo’s Original Stash brand is performing exceptionally and is competing well with the black market products, thanks to its smart packaging and value pricing. Besides, the successful launch of Hash and other new products should further support its sales and margins in the long run.

Hexo remains optimistic and expects its growing market share and cost reduction initiatives to support its goal of achieving a positive adjusted EBITDA in the first half of fiscal 2021. While things are improving for Hexo, investors shouldn’t miss the opportunity of buying it low.

Neptune Wellness Solutions

Neptune Wellness is a diversified health and wellness company, which has shown remarkable growth in the marijuana space. The company’s cannabis segment has been driving its overall revenues, and the company expects the momentum to sustain in the quarters ahead.

In the most recent quarter, revenues from the cannabis segment grew around 43% on a sequential basis. Meanwhile, Neptune Wellness remains optimistic and expects to report 300-400% year over year growth in its top line for the first quarter of fiscal 2021, driven primarily by the sustained momentum in the cannabis segment.

Neptune Wellness has been growing its production and sales capacity, adding new avenues for growth. Moreover, it has recently obtained a sales license from Health Canada, which would help expand its proprietary cannabis brands nationwide and boost its revenue growth rate.

Though Neptune is not profitable yet, its focus on driving revenues, production expansion, low-cost supply-chain infrastructure, and operating efficiency should help in generating positive EBITDA in the future.

At the current price levels, Neptune stock looks an attractive investment for young investors for their retirement portfolio.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »